This document provides an agenda for the ONE3 HEMATOLOGY conference taking place on July 9-10, 2011 in Kuala Lumpur, Malaysia. The agenda includes times for registration, welcoming addresses, three sessions of presentations on topics in hematology such as new anticoagulants and molecularly targeted therapies, and question and answer periods. There will also be an introduction of a keynote speaker, breaks for tea and lunch, and a session by the Malaysian Society of Haematology Examiner Board.

1. 2011 ONE3 HEMATOLOGY - Post EHA 2011 Updates
Le Meridien Kuala Lumpur, 9-10 JULY 2011
RECEPTION: SATURDAY 9 JULY 2011
1500 - 1900 Accommodation check-in (applicable only)
1900 - 2100 Welcome dinner
ONE3 HEMATOLOGY: SUNDAY 10 JULY 2011
0800 - 0840 Registration
0840 - 0900 Welcoming address: Towards Molecular Targetting Therapy Dato' Dr. Chang Kian Meng
0900 - 0910 Session 1 Introduction Dr. Jameela Sathar
0910 - 0930 New Anticoagulants for Long Term Treatment Dr. Tan Swee Looi
0930 - 0950 The role of thrombopoietic agents in ITP Dr. Chew Teng Keat
0950 - 1010 Oral Iron Chelators are First Choice Treatment for All Patients Dr. Ahlam Naila Kori
with Transfusional Iron Overload
1010 - 1035 Questions and answers Dr. Jameela Sathar
1035 - 1050 Tea break
1050 - 1100 Session 2 Introduction Dr. Goh Ai Sim
1100 - 1120 DLBCL - Treatment Decisions Based on Molecular Features Dato' Dr. Chang Kian Meng
1120 - 1140 First Line Therapy for Multiple Myeloma in 2011 Dr. Haris Abdul Rahman
1140 - 1200 Today's treatment of Hodgkins lymphoma Dr. Leong Kin Wah
1200 - 1230 Questions and answers Dr. Goh Ai Sim
1230 - 1330 Lunch
1330 - 1340 Introducing Dr Susan Branford Dato' Dr. Chang Kian Meng
1340 - 1400 Detection of Imatinib Resistance and Monitoring on Dr. Susan Branford
Subsequent Therapy (awaiting confirmation)
1400 - 1415 Questions and answers Dato' Dr. Chang Kian Meng
1415 - 1425 Session 3 Introduction Dato' Dr. Chang Kian Meng
1425 - 1445 Management of Newly Diagnosed CML Patients Dr. Ng Soo Chin
1445 - 1505 ALL in Elderly Assoc. Prof. Wong Chieh Lee
1505 - 1525 Guiding Treatment by Molecular Diagnostics (AML) Dr. Chiang Su Kien
1525 - 1600 Questions and answers Dato' Dr. Chang Kian Meng
1600 - 1630 Tea break & Glivec for Rare Diseases
1630 - 1715 Malaysian Society of Haematology (MSH) Examiner Board Dr. Goh Ai Sim